The immunomodulatory effect 1,25 (OH)2 D3 on TLR 2 and TLR4 expression on monocytes of patients with type II diabetes mellitus
Archives of Medical Laboratory Sciences,
Vol. 1 No. 1 (2015),
21 May 2015
https://doi.org/10.22037/amls.v1i1.8963
Abstract
Background: Recent studies have shown the immunomodulatory effect of vitamin D3 through down-regulation of Toll-like receptor (TLR) expression in human monocytes. In this study, the effects of vitamin D treatment on TLR2 and TLR4 expression on monocytes derived from type 2 diabetes was investigated.
Materials and Methods: To assess the influence of vitamin D3 on expression of TLR2 and TLR4 on monocytes from patients with type II diabetes, peripheral blood sample was taken of 30 patients. Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifuge and then monocytes were isolated from these cells with using the magnetic activated cell sorting (MACS). To investigate the effect of vitamin D3 on the expression of TLR2 and TLR4, monocytes were cultured in the presence of vitamin D3 (10-9 M) for 48 hours. Then the expression of TLR2 and TLR4 was determined by Real-time PCR.
Results: We found that vitamin D3 suppresses the mRNA expression of TLR2 and TLR4 in patients with type II diabetes. TLR2 and TLR4 expression in the patients exposed to vitamin D3 were significantly decreased in comparison with patients who were not treated with vitamin D3.
Conclusion: It can be concluded that vitamin D3 supplements may be further analyzed as a therapeutic option by reducing TLR2 and TLR4 expression in patients with type II diabetes.
- TLR
- monocyte
- type II diabetes
How to Cite
References
Shadman Z, Rastmanesh R, Hedayati M, Taleban F, Saadat N, Tahbaz F, et al. Effects of Conjugated Linoleic Acid on Insulin Sensitivity and Diabetes Markers in Type 2 Diabetic Patients. Iranian Journal of Endocrinology & Metabolism. 2009;221.
Mohan R, Dasu, Sridevi D, Samuel P, Bsishwarlal J. Increased Toll-Like Receptor (TLR)Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects. DIABETES CARE. 2010;33(4):861-8.
Wellen KE, Inflammation, stress and diabetes. Clin invest. 2005;115:1111-1119.
Shi H, Inouvy K, Tzameli I, Yin H, Flier JS. TLR4 links innate imunity and fatty acid-induced insulin resistance. Cline invest, 2006;116:3015-3025.
Hill H, Rallison M,Santos JI, Charette RP, Kitahara M. Fanctional and metabolic abnormalities of diabetic monocytes. Adv Expt Med Biol. 1980;69:621-7.
Susan W, Li W. Toll-Like Receptors and Diabetes. Immunology of Diabetes V: Ann NY Acad Sci. 2008;1150:123-32.
Tsan MF. Endogenous ligands of Toll-Like receptors. leucocytes Biol. 2004;76:514-9.
Doyle SL, ONL. Toll-Like receptors: from the discovery of NF kappaB to new insights into transcriptional regulations in innate immunity. Biochem pharmacol. 2006;72(9):1102-13.
Shirinzadeh M, Shaker R, Hushyarrad A, Golestan B. Evaluation of serum calcium and vitamin D In patients with type II diabetes. 2006.
Haffner SM, Ronnemaa T, Pyorala K, Laacso M. Mortality from cronary heart disease in subjects with type 2 diabetes and nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.
Curtiss LK, T.P., Emerging roll of Toll-like receptor in atherosclerosis. Lipid Res, 2009. 50: p. 340-345.
Bagarolli RA, SM, Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with type 2 diabetes. Diabetes Complications J. 2009.
Wong FS, Wen L, Toll-Like Receptors and Diabetes. Immunology of Diabetes V: Ann. N.Y. Acad. Sci. 2008;1150:123-32.
Devaraj SRockwood J, Winter W, Griffen SC, Jialal I. Increased Toll-Like Receptor (TLR) 2 and TLR Expression inMonocytes from Patients with Type 1Diabetes: Further Evidence of a Proinflammatory State. Journal of Clinical Endocrinology & Metabolism 2008. 93(2):578-83.
Liu S, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:2926-32.
Pittas AG, Li T, Van-Dam RM, Willett WC, Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29:650-6.
Muscogiuri GS, Ajjan GP, Mezza R, Pilz T, Prioletta S, Scragg A, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012;22(2):81-7.
Chagas CEA, Carolina-Martini M, Araújo-Rogero L, Macedo M. Focus on Vitamin D, Inflammation and Type 2 Diabetes. Nutrients, 2012;4(1):52-67.
Do JE, Kwon SY, Park S, LE S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology. 2008;47(6):840-8.
- Abstract Viewed: 624 times
- PDF Downloaded: 221 times